Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-009985
Filing Date
2025-05-21
Accepted
2025-05-21 16:13:14
Documents
1
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3651
  Complete submission text file 0001062993-25-009985.txt   5250
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752
Business Address
Ferrara Robert L (Reporting) CIK: 0001792987 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 25973270